Correlation Between Veracyte and Oncternal Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Oncternal Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Oncternal Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Oncternal Therapeutics, you can compare the effects of market volatilities on Veracyte and Oncternal Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Oncternal Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Oncternal Therapeutics.
Diversification Opportunities for Veracyte and Oncternal Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and Oncternal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Oncternal Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncternal Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Oncternal Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncternal Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Oncternal Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Oncternal Therapeutics
If you would invest (100.00) in Oncternal Therapeutics on December 2, 2024 and sell it today you would earn a total of 100.00 from holding Oncternal Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Veracyte vs. Oncternal Therapeutics
Performance |
Timeline |
Veracyte |
Oncternal Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Veracyte and Oncternal Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Veracyte and Oncternal Therapeutics
The main advantage of trading using opposite Veracyte and Oncternal Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Oncternal Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncternal Therapeutics will offset losses from the drop in Oncternal Therapeutics' long position.Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Oncternal Therapeutics vs. CytomX Therapeutics | Oncternal Therapeutics vs. Assembly Biosciences | Oncternal Therapeutics vs. Instil Bio | Oncternal Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |